FDA Adverse Event Reporting System Quarterly Data Extract Files
Principal Investigator(s): View help for Principal Investigator(s) United States Department of Health and Human Services. Food and Drug Administration
Version: View help for Version V3
| Name | File Type | Size | Last Modified |
|---|---|---|---|
| Data-Files | 03/16/2025 09:34:PM | ||
| Supplementary-Information | 03/16/2025 07:37:PM |
Project Citation:
Project Description
From the FAERS Quarterly Data Extract Files Website:
The files listed on this page contain raw data extracted from the AERS database for the indicated time ranges and are not cumulative. Users of these files need to be familiar with creation of relational databases using applications such as ORACLE®, Microsoft Office Access, MySQL® and IBM DB2 or the use of ASCII files with SAS® analytic tools. A simple search of FAERS data cannot be performed with these files by persons who are not familiar with creation of relational databases. However, you can get a summary FAERS report for a product by sending a Freedom of Information Act (FOIA) request to FDA. You can also request individual case reports by submitting a FOIA request listing case report numbers. The quarterly data files, which are available in ASCII or SGML formats, include:
- demographic and administrative information and the initial report image ID number (if available);
- drug information from the case reports;
- reaction information from the reports;
- patient outcome information from the reports;
- information on the source of the reports;
- a "README" file containing a description of the files.
For more details: Summary of Changes for the 2014 Q3 Quarterly Date Extract (PDF -71 KB)
link: https://www.fda.gov/drugs/surveillance/postmarketing-adverse-event-reporting-compliance-program
Scope of Project
Related Publications
Published Versions
Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.
This material is distributed exactly as received from the data depositor. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.